Guardian Investment Management Abb Vie Inc. Transaction History

Guardian Investment Management

$124 Million
Q1 2025

A detailed history of Guardian Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Investment Management holds 16,400 shares of ABBV stock, worth $3.05 Million. This represents 2.78% of its overall portfolio holdings.

Number of Shares

16,400

Previous 17,801 7.87%

Holding current value

$3.05 Million

Previous $3.16 Million 8.63%

% of portfolio

2.78%

Previous 2.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$169.2 - $216.66 $237,049 - $303,540	-1,401 Reduced 7.87%	16,400 $3.44 Million
Q4 2024 Jan 16, 2025	SELL	$164.99 - $203.87 $74,245 - $91,741	-450 Reduced 2.47%	17,801 $3.16 Million
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $241,664 - $294,011	-1,475 Reduced 7.48%	18,251 $3.6 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $77,395 - $90,380	-500 Reduced 2.47%	19,726 $3.38 Million
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $302,858 - $345,079	-1,895 Reduced 8.57%	20,226 $3.68 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $96,320 - $108,479	-700 Reduced 3.07%	22,121 $3.43 Million
Q3 2023 Oct 13, 2023	BUY	$133.59 - $154.65 $3,606 - $4,175	27 Added 0.12%	22,821 $3.4 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $890,864 - $1.11 Million	-6,723 Reduced 22.78%	22,794 $3.07 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $824,277 - $949,278	5,700 Added 23.93%	29,517 $4.7 Million
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $429,472 - $492,576	-3,200 Reduced 11.84%	23,817 $3.2 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $79,188 - $98,250	600 Added 2.27%	27,017 $4.38 Million
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $308,560 - $350,262	-2,900 Reduced 9.89%	26,417 $2.85 Million
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $21,042 - $23,442	-200 Reduced 0.68%	29,317 $3.3 Million
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $95,307 - $127,535	-1,299 Reduced 4.22%	29,517 $2.9 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $12,900 - $19,558	-200 Reduced 0.64%	30,816 $2.35 Million
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $6,298 - $7,572	-100 Reduced 0.32%	31,016 $2.35 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $2,545 - $2,996	-33 Reduced 0.11%	31,116 $2.51 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $80,419 - $99,178	1,033 Added 3.43%	31,149 $2.87 Million
Q3 2018 Oct 19, 2018	BUY	$88.91 - $98.84 $17,782 - $19,768	200 Added 0.67%	30,116 $2.85 Million
Q2 2018 Jul 13, 2018	BUY	$89.78 - $106.23 $44,890 - $53,115	500 Added 1.7%	29,916 $2.77 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $46,005 - $61,605	-500 Reduced 1.67%	29,416 $2.78 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $134,340 - $147,315	-1,500 Reduced 4.77%	29,916 $2.89 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $2.19 Million - $2.8 Million	31,416	31,416 $2.79 Million

Others Institutions Holding ABBV

# of Institutions

4,260

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $328B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.

Account

Guardian Investment Management Abb Vie Inc. Transaction History